Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1986 2
1988 3
1989 3
1990 3
1991 1
1992 2
1993 2
1994 1
1999 2
2000 1
2001 1
2003 2
2005 2
2006 2
2007 4
2008 9
2009 2
2010 5
2011 3
2012 4
2013 3
2014 5
2015 5
2016 7
2018 5
2019 6
2020 5
2021 7
2022 6
2023 9
2024 11
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Ecopharmacovigilance for better health.
Velo G, Moretti U. Velo G, et al. Among authors: moretti u. Drug Saf. 2010 Nov 1;33(11):963-8. doi: 10.2165/11539380-000000000-00000. Drug Saf. 2010. PMID: 20825251 No abstract available.
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.
Menniti-Ippolito F, Aiello E, Arzenton E, Assisi A, Blaznik U, Castenmiller JJM, Crevani M, de Clock D, Di Giacomo S, Emendi S, Gonella LA, Ippoliti I, Lindquist M, Magro L, Mazzanti G, Mores N, Moretti U, Moro PA, Novakovic B, Raschi E, Siksna I, Valetto MR, Vitalone A, Vo Van Regnault G. Menniti-Ippolito F, et al. Among authors: moretti u. Drug Saf. 2023 May;46(5):435-437. doi: 10.1007/s40264-023-01284-6. Epub 2023 Apr 6. Drug Saf. 2023. PMID: 37022637 No abstract available.
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
Gastaldon C, Schoretsanitis G, Arzenton E, Raschi E, Papola D, Ostuzzi G, Moretti U, Seifritz E, Kane JM, Trifirò G, Barbui C. Gastaldon C, et al. Among authors: moretti u. Drug Saf. 2022 Dec;45(12):1539-1549. doi: 10.1007/s40264-022-01246-4. Epub 2022 Nov 18. Drug Saf. 2022. PMID: 36400895 Free PMC article.
Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study.
Bellini A, Finocchietti M, Rosa AC, Masiero L, Trapani S, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT Study Group. Bellini A, et al. BMJ Open. 2024 Nov 12;14(11):e087373. doi: 10.1136/bmjopen-2024-087373. BMJ Open. 2024. PMID: 39532354 Free PMC article.
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
Luxi N, Giovanazzi A, Arcolaci A, Bonadonna P, Crivellaro MA, Cutroneo PM, Ferrajolo C, Furci F, Guidolin L, Moretti U, Olivieri E, Petrelli G, Zanoni G, Senna G, Trifirò G. Luxi N, et al. Among authors: moretti u. BioDrugs. 2022 Jul;36(4):443-458. doi: 10.1007/s40259-022-00536-8. Epub 2022 Jun 13. BioDrugs. 2022. PMID: 35696066 Free PMC article. Review.
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health.
Lunghi C, Valetto MR, Caracciolo AB, Bramke I, Caroli S, Bottoni P, Castiglioni S, Crisafulli S, Cuzzolin L, Deambrosis P, Giunchi V, Grisotto J, Marcomini A, Moretti U, Murgia V, Pandit J, Polesello S, Poluzzi E, Romizi R, Scarpa N, Scroccaro G, Sorrentino R, Sundström A, Wilkinson J, Paolone G. Lunghi C, et al. Among authors: moretti u. Drug Saf. 2025 Apr;48(4):315-320. doi: 10.1007/s40264-024-01497-3. Epub 2024 Dec 10. Drug Saf. 2025. PMID: 39656351 No abstract available.
Editorial: Traditional and innovative approaches for signal detection.
Tuccori M, Bate A, Moretti U, Trifirò G. Tuccori M, et al. Among authors: moretti u. Front Drug Saf Regul. 2024 Feb 6;4:1373689. doi: 10.3389/fdsfr.2024.1373689. eCollection 2024. Front Drug Saf Regul. 2024. PMID: 40979386 Free PMC article. No abstract available.
Cosmetovigilance: the 'beautiful' risk.
Moretti U, Velo G. Moretti U, et al. Drug Saf. 2008;31(5):437-9. doi: 10.2165/00002018-200831050-00012. Drug Saf. 2008. PMID: 18422387
117 results